Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy.

Mehta SA, Ahmed A, Laverty M, Holzman RS, Valentine F, Sivapalasingam S.

Clin Infect Dis. 2011 Sep;53(5):490-6. doi: 10.1093/cid/cir432.

2.

Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya.

Mehta SA, Ahmed A, Kariuki BW, Said S, Omasete F, Mendillo M, Laverty M, Holzman R, Valentine F, Sivapalasingam S.

Am J Trop Med Hyg. 2010 Sep;83(3):565-70. doi: 10.4269/ajtmh.2010.09-0629.

3.

Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.

Kiwuwa-Muyingo S, Kikaire B, Mambule I, Musana H, Musoro G, Gilks CF, Levin JB, Walker AS.

AIDS. 2014 Nov 13;28(17):2579-88. doi: 10.1097/QAD.0000000000000447.

PMID:
25574960
4.

Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.

McGrath CJ, Njoroge J, John-Stewart GC, Kohler PK, Benki-Nugent SF, Thiga JW, Etyang A, Chung MH.

J Neurovirol. 2012 Jun;18(3):200-4. doi: 10.1007/s13365-012-0098-x. Epub 2012 Apr 17.

5.

Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.

Evans D, Takuva S, Rassool M, Firnhaber C, Maskew M.

J Neurovirol. 2012 Jun;18(3):162-71. doi: 10.1007/s13365-012-0093-2. Epub 2012 Apr 20.

PMID:
22528477
6.

Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen.

Lee AJ, Bosch RJ, Evans SR, Wu K, Harrison T, Grant P, Clifford DB.

J Neurovirol. 2015 Apr;21(2):210-8. doi: 10.1007/s13365-015-0327-1. Epub 2015 Feb 13.

7.
8.

Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.

Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F.

Clin Ther. 2007 Jul;29(7):1448-55.

PMID:
17825696
9.

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X.

AIDS. 2007 Nov 30;21(18):2483-91.

PMID:
18025885
10.

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.

Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, Guèye PM, Lanièce I, Dieng AB, Diouf A, Laurent C, Mboup S, Sow PS, Delaporte E.

AIDS. 2006 May 12;20(8):1181-9.

PMID:
16691070
11.

Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women.

Dao CN, Peters PJ, Kiarie JN, Zulu I, Muiruri P, Ong'ech J, Mutsotso W, Potter D, Njobvu L, Stringer JS, Borkowf CB, Bolu O, Weidle PJ.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1149-55. doi: 10.1089/AID.2010.0345. Epub 2011 May 4.

PMID:
21417949
12.

High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy.

Hamada Y, Nishijima T, Watanabe K, Komatsu H, Tsukada K, Teruya K, Gatanaga H, Kikuchi Y, Oka S.

Clin Infect Dis. 2012 Nov;55(9):1262-9. doi: 10.1093/cid/cis621. Epub 2012 Jul 19.

PMID:
22820542
13.

Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.

Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J, Van Leth F, Mayanja-Kizza H, Kestens L, Mugerwa RD, Reiss P, Colebunders R; TB-IRIS Study Group.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):32-7. doi: 10.1097/QAI.0b013e3182255dc2.

PMID:
21654499
14.

Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study.

Homsy J, Bunnell R, Moore D, King R, Malamba S, Nakityo R, Glidden D, Tappero J, Mermin J.

PLoS One. 2009;4(1):e4149. doi: 10.1371/journal.pone.0004149. Epub 2009 Jan 8.

15.

Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.

Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S.

J Infect. 2007 Nov;55(5):464-9. Epub 2007 Aug 22.

PMID:
17714788
16.

Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.

Pahuja M, Grobler A, Glesby MJ, Karim F, Parker G, Gumede S, Naidoo K.

Antivir Ther. 2012;17(4):737-43. doi: 10.3851/IMP2087. Epub 2012 Mar 13.

17.

Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals.

Lohse N, Obel N, Kronborg G, Laursen A, Pedersen C, Larsen CS, Kvinesdal B, Sørensen HT, Gerstoft J.

AIDS. 2005 May 20;19(8):815-22.

PMID:
15867496
18.

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.

Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L; Médecins Sans Frontieres.

AIDS. 2006 May 12;20(8):1163-9.

PMID:
16691068
19.
20.

CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?

Newell ML, Patel D, Goetghebuer T, Thorne C; European Collaborative Study.

J Infect Dis. 2006 Apr 1;193(7):954-62. Epub 2006 Feb 23.

PMID:
16518757

Supplemental Content

Support Center